Gujarat Themis Biosyn Limited — Credit Ratings, 17-07-2026: Credit Rating- Revision

Gujarat Themis Biosyn's bank facilities received CARE BBB (RWN) for Long Term and CARE A3+ (RWN) for Short Term from CARE Ratings. The ratings are on 'Rating Watch with Negative Implications' due to significant planned acquisitions worth ~₹3,000 Cr, roughly 10x its tangible net worth. Funding mix uncertainty, including a critical ₹1,000 Cr QIP, is a key concern.